The review of pharmaceutical legislation with the aim of guaranteeing access to affordable medicines and health products in the EU, must include both existing legislation on medicine and on medical devices. Considering both legislative fields, the following aspects should be considered: • Support for research and innovation of medicines and health products.
LER
LERU
Other · Belgium · EU Transparency Register 823693912705-83
7
positions filed
in the 665 files tracked
7
legislative files
of 665 tracked
4
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 163 think tanks and research institutions on this site, they rank #27 by legislative files engaged, a count of participation, not a measure of influence.
5.8
declared lobbying FTE
self-declared
€1M+
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2014
in the register since
Declares membership of
- LERU, League of European Research Universities https://www.leru.org/activities/partnerships-collaboration
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Think tanks and research institutions
- Registered as
- League of European Research Universities (LERU)
- Head office
- Leuven, Belgium
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track LERU in PolicySpeak: request access →
Work at LERU? so we know who speaks for it.
Their record over time
LERU filed 7 positions between 1 Feb 2021 and 23 Sept 2026, across 7 of the 665 legislative files tracked here, attaching a full position paper 4 times.
2021 · 4 filed2024 · 1 filed2025 · 1 filed2026 · 1 filed
What they argued
The League of European Research Universities (LERU) are very enthusiastic about this proposal. We think it provides a very ambitious framework that will help the health sector to move forward in digitalisation. We very much approve of the federated approach. Furthermore, it pushes all member states to stop thinking and start acting. It has a high potential to facilitate research and healthcare across the EU.
LERU (https://www.leru.org) is an association of 24 leading research-intensive universities in Europe. Research-intensive universities are involved in all scales of research infrastructures; from small, specialised databases, and core facilities into specific technologies to the larger EFSRI-type projects which are more well known.
LERU Office Ref. Ares(2026)8988687 - 23/09/2026 [address removed], Belgium LERU Contribution to the Revision of the EIT Regulation and Strategic Innovation Agenda General perspective The comments below reflect the experiences of many LERU members in the EIT ecosystem. They are drafted by the University of Barcelona (Vice-rectorate for Entrepreneurship, Innovation and Transfer) and supported and endorsed by LERU.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The League of European Research Universities (LERU) is an association of 24 leading research intensive universities in Europe. In this response, we outline how option 1, going further with existing measures and exploiting synergies better, is LERUs preferred option, as it would afford flexibility in responding to crises in a timely measure, and would allow for participation of universities within those countries…
LERU welcomes the proposal to strengthen the role of the European Medicines Agency to address public health emergencies. We would like to highlight that "regulatory preparedness" can be ensured by putting in place and maintaining a strong evidence/regulatory science base to underpin decision-making.
Overall, an increased EU collaboration and joint preparedness for future health crises is a laudable initiative with many potential benefits for Europe’s major research universities. Some points that deserve more specific comments are as follows: The plan for a network of reference laboratories should more specifically take into account also academic facilities and national research infrastructures to optimise…
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put LERU next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 101.
Is this your organization?
Everything on this page comes from LERU’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.